Skip to content

Study on the evaluation of effective blood transfusion and transfusion efficacy in geriatric clinics

Study on the evaluation of effective blood transfusion and transfusion efficacy in geriatric clinics

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080415
Enrollment
Unknown
Registered
2024-01-29
Start date
2023-02-06
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood type and transfusion

Interventions

Infusion of red blood cells group - experimental group:Patients and blood donors were identified by ABO blood grouping and RHCcEe typing, and blood components with the same RH typing were selected for
Infusion of red blood cells group - control group:Patients and blood donors were routinely blood typed for ABO blood grouping and RHD type, cross-matched and then transfused for compatibility.

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1: Age greater than or equal to 60 years 2: Need for at least one transfusion of red blood cells during hospitalization 3: Subject (or the patient's legal representative) has signed an informed consent form

Exclusion criteria

Exclusion criteria: 1: Patients with significant uncontrollable overt blood loss requiring urgent resuscitation 2: Patients with severe ischemic cardiovascular disease or ventilatory dysfunction 3: Patients whose first irregular antibody screening suggests the presence of non-specific blood group antibodies (e.g. autoantibodies) that make blood matching difficult 4: Patients with special or rare blood types (subtype A or Rh D-negative patients, etc.) 5: Patients who have participated in other clinical studies (e.g., clinical studies such as cell therapy) within 2 months prior to the start of the study 6: Patients or their legal representatives are unwilling to sign a written informed consent or to comply with the study protocol

Design outcomes

Primary

MeasureTime frame
Hemoglobin count;erythrocyte count;erythrocyte pressure;Mean erythrocyte volume;Mean red cell hemoglobin;Mean red cell hemoglobin concentration;

Secondary

MeasureTime frame
erythrocyte distribution width;

Countries

China

Contacts

Public ContactMa Wanru

Beijing Hospital

m65717902@126.com+86 188 1176 9918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026